PL1767219T3 - Trwałe kompozycje diklofenaku do iniekcji - Google Patents

Trwałe kompozycje diklofenaku do iniekcji

Info

Publication number
PL1767219T3
PL1767219T3 PL07075004T PL07075004T PL1767219T3 PL 1767219 T3 PL1767219 T3 PL 1767219T3 PL 07075004 T PL07075004 T PL 07075004T PL 07075004 T PL07075004 T PL 07075004T PL 1767219 T3 PL1767219 T3 PL 1767219T3
Authority
PL
Poland
Prior art keywords
diclofenac
cyclodextrin
salt
stable injectable
pharmaceutically acceptable
Prior art date
Application number
PL07075004T
Other languages
English (en)
Inventor
Lawrence John Penkler
Original Assignee
Shimoda Biotech Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34826259&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1767219(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shimoda Biotech Pty Ltd filed Critical Shimoda Biotech Pty Ltd
Publication of PL1767219T3 publication Critical patent/PL1767219T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
PL07075004T 2004-03-10 2004-11-30 Trwałe kompozycje diklofenaku do iniekcji PL1767219T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55135104P 2004-03-10 2004-03-10
EP04257437A EP1574221B1 (en) 2004-03-10 2004-11-30 Stable injectable diclofenac compositions
EP07075004A EP1767219B1 (en) 2004-03-10 2004-11-30 Stable injectable diclofenac compositions

Publications (1)

Publication Number Publication Date
PL1767219T3 true PL1767219T3 (pl) 2010-06-30

Family

ID=34826259

Family Applications (2)

Application Number Title Priority Date Filing Date
PL04257437T PL1574221T3 (pl) 2004-03-10 2004-11-30 Trwałe kompozycje diklofenaku do zastrzyków
PL07075004T PL1767219T3 (pl) 2004-03-10 2004-11-30 Trwałe kompozycje diklofenaku do iniekcji

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL04257437T PL1574221T3 (pl) 2004-03-10 2004-11-30 Trwałe kompozycje diklofenaku do zastrzyków

Country Status (20)

Country Link
US (2) US20050238674A1 (pl)
EP (2) EP1574221B1 (pl)
JP (1) JP2007528384A (pl)
KR (1) KR20070028331A (pl)
AT (2) ATE364402T1 (pl)
AU (1) AU2004317520B2 (pl)
BR (1) BRPI0418474A (pl)
CA (1) CA2555429C (pl)
CY (1) CY1106824T1 (pl)
DE (2) DE602004006952T2 (pl)
DK (2) DK1767219T3 (pl)
ES (2) ES2287658T3 (pl)
HK (1) HK1079118A1 (pl)
IL (1) IL177529A (pl)
MX (1) MXPA06010336A (pl)
PL (2) PL1574221T3 (pl)
PT (2) PT1574221E (pl)
SI (2) SI1574221T1 (pl)
WO (2) WO2005092387A1 (pl)
ZA (2) ZA200607631B (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006095363A2 (en) 2005-02-01 2006-09-14 Troikaa Pharmaceuticals Ltd Injectable preparations of diclofenic and its pharmaceutically acceptable salts
US20060205080A1 (en) * 2005-03-01 2006-09-14 David Frey Formulations for therapeutic viruses having enhanced storage stability
AU2012209035B9 (en) * 2006-03-28 2014-05-22 Javelin Pharmaceuticals, Inc. Formulations of low dose diclofenac and beta-cyclodextrin
WO2007112272A2 (en) 2006-03-28 2007-10-04 Javelin Pharmaceuticals, Inc. Formulations of low dose diclofenac and beta-cyclodextrin
CN101410012A (zh) 2006-03-28 2009-04-15 杰佛林制药公司 低剂量的非甾体抗炎药和β-环糊精的制剂
CL2007003877A1 (es) 2007-12-28 2008-06-27 Univ De Concepcion Lab Androma Composicion farmaceutica que comprende un complejo de inclusion formado por disulfiram y una ciclodextrina; y su uso para el tratamiento de la dependencia de alcohol y cocaina.
US20100022652A1 (en) * 2008-07-28 2010-01-28 Tyco Healthcare Group Lp Antimicrobial and Anticoagulant Compositions and Methods
AU2010224866C1 (en) 2009-03-16 2015-01-15 Genmedica Therapeutics Sl Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders
US8466197B2 (en) 2010-12-14 2013-06-18 Genmedica Therapeutics Sl Thiocarbonates as anti-inflammatory and antioxidant compounds useful for treating metabolic disorders
GB201021267D0 (en) 2010-12-15 2011-01-26 Reckitt Benckiser Healthcare Int Ltd Novel pharmaceutical formulation
BR112014001335A2 (pt) * 2011-07-20 2017-02-21 Hospira Inc método para tratar dor pós-operatória em um mamífero e método para tratar dor em um mamífero
BR112014003167A2 (pt) * 2011-08-11 2017-03-01 Cross Sa composição farmacêutica constituída por um fármaco que contém pelo menos uma função toxicofora e n-acetil-l-cisteína
KR101260636B1 (ko) 2012-11-29 2013-05-13 씨제이제일제당 (주) 안정화된 페메트렉시드 제제
US20140187635A1 (en) 2012-12-28 2014-07-03 Themis Medicare Limited Diclofenac compositions
US20140275261A1 (en) 2013-03-15 2014-09-18 Dr. Reddy's Laboratories, Inc. Diclofenac parenteral compositions
KR101485243B1 (ko) 2013-05-08 2015-01-21 씨제이헬스케어 주식회사 안정화된 페메트렉시드 제제
US11110073B2 (en) 2017-03-24 2021-09-07 Cadila Healthcare Limited Storage stable aqueous injectable solution comprising diclofenac
US20190142789A1 (en) * 2017-08-09 2019-05-16 Piedmont Animal Health, Llc Therapeutic formulations and uses thereof
US20220280463A1 (en) 2019-09-09 2022-09-08 Ftf Pharma Private Limited Pharmaceutical formulations comprising diclofenac
US11707443B2 (en) 2019-09-26 2023-07-25 Rk Pharma Inc. Storage stable aqueous parenteral solutions comprising diclofenac
CN110872942B (zh) * 2019-10-24 2021-09-28 中国石油化工股份有限公司 油藏注采耦合方式下不同作用力对采收率贡献的研究方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3446873A1 (de) * 1984-12-21 1986-07-10 Merckle Gmbh Fluessige diclofenac-zubereitungen
US5690954A (en) * 1987-05-22 1997-11-25 Danbiosyst Uk Limited Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material
US5389681A (en) * 1992-10-22 1995-02-14 Ciba-Geigy Corporation Parenteral solutions for diclofenac salts
IL111184A (en) * 1993-10-08 2000-08-13 Farmarc Nederland B V Of Cito Crystalline inclusion complex of diclofenac with unsubstituted beta-cyclodextrin
ZA949182B (en) * 1993-12-02 1995-07-26 South African Druggists Ltd Pharmaceutical composition
EP0785780A1 (en) * 1994-10-10 1997-07-30 Novartis AG Ophthalmic and aural compositions containing diclofenac potassium
US5821237A (en) * 1995-06-07 1998-10-13 The Procter & Gamble Company Compositions for visually improving skin
AU5774796A (en) * 1995-06-13 1997-01-09 Dyer, Alison Margaret Pharmaceutical compositions containing lornoxicam and cyclod extrin
TW434023B (en) * 1995-09-18 2001-05-16 Novartis Ag Preserved ophthalmic composition
FR2751875B1 (fr) * 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
AU4979700A (en) * 1999-05-03 2000-11-17 Battelle Memorial Institute Compositions for aerosolization and inhalation
DE50104197D1 (de) * 2000-12-28 2004-11-25 Fresenius Kabi Austria Gmbh Gr Stabile Infusionslösung von Diclofenac-Salzen, deren Herstellung und Verwendung
ATE326985T1 (de) * 2002-02-01 2006-06-15 Shimoda Biotech Pty Ltd Lyophilisierte pharmazeutische zusammensetzung von propofol
MXPA04008171A (es) * 2002-02-22 2004-11-26 Pharmacia Corp Formulacion oftalmica con sistema de goma.

Also Published As

Publication number Publication date
PT1574221E (pt) 2007-07-09
ATE364402T1 (de) 2007-07-15
SI1574221T1 (sl) 2007-10-31
HK1079118A1 (en) 2006-03-31
ATE454905T1 (de) 2010-01-15
ES2287658T3 (es) 2007-12-16
WO2005086763A2 (en) 2005-09-22
DE602004006952T2 (de) 2008-02-14
WO2005086763A3 (en) 2006-03-02
DK1574221T3 (da) 2007-07-16
DK1767219T3 (da) 2010-05-10
PL1574221T3 (pl) 2007-10-31
ZA200607631B (en) 2008-10-29
DE602004006952D1 (de) 2007-07-26
MXPA06010336A (es) 2007-02-16
EP1767219A3 (en) 2007-04-25
IL177529A0 (en) 2006-12-10
EP1767219B1 (en) 2010-01-13
ZA200805860B (en) 2009-05-27
US20050238674A1 (en) 2005-10-27
KR20070028331A (ko) 2007-03-12
WO2005092387A1 (en) 2005-10-06
CA2555429A1 (en) 2005-10-06
AU2004317520A1 (en) 2005-10-06
EP1767219A2 (en) 2007-03-28
IL177529A (en) 2013-08-29
PT1767219E (pt) 2010-02-15
US20120142779A1 (en) 2012-06-07
BRPI0418474A (pt) 2007-06-19
EP1574221A1 (en) 2005-09-14
CA2555429C (en) 2010-05-18
CY1106824T1 (el) 2012-05-23
AU2004317520B2 (en) 2011-06-09
EP1574221B1 (en) 2007-06-13
JP2007528384A (ja) 2007-10-11
SI1767219T1 (sl) 2010-03-31
DE602004025151D1 (de) 2010-03-04
ES2336034T3 (es) 2010-04-07

Similar Documents

Publication Publication Date Title
IL177529A0 (en) Stable injectable diclofenac compositions
TW200728307A (en) Novel spirochromanone derivatives
WO2007002559A8 (en) Pyrazole based lxr modulators
WO2009146024A8 (en) Etomidate analogues with improved pharmacokinetic and pharmacodynamic properties
TW200612958A (en) Substituted imidazole derivatives
MX2007004699A (es) Derivados de indol y bencimidazol.
NZ593110A (en) pteridinone derivatives as MODULATORS OF TOLL-LIKE RECEPTORS
WO2009144555A8 (en) Pyrazolospiroketone acetyl-coa carboxylase inhibitors
WO2007147882A3 (en) Aqueous suspensions of tmc278
PT2310356E (pt) Derivados de adamantildiamida e a sua utilização
WO2010030704A3 (en) Antibacterial aminoglycoside analogs
MY145074A (en) Thiazolidin-4-one derivatives
WO2008048589A3 (en) Compounds and methods for treatment of hcv
WO2010018549A3 (en) Therapeutic compositions containing macitentan
TW200621785A (en) Analgesic
EP1944027A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF NEPHRITIS AND METHOD FOR PRODUCING THE SAME
EP2077111A4 (en) ANTIDEPRESSANT AGENT
WO2008063548A3 (en) 5, 6, or 7-substituted-s- (hetero)arylisoquinolinamine derivatives as antitumor agents
WO2008054767A3 (en) N4 modifications of pyrimidine analogs and uses thereof
WO2007000655A3 (en) Novel pyrazolopyrimidinone derivatives
WO2009053654A3 (fr) Prodrogues phosphoesters de la gemcitabine comme agents anticancereux
MY150776A (en) Combination of a bis-thiazolium salt or a precursor thereof and artemisinin or a derivative thereof for treating acute malaria
WO2007047881A3 (en) Method for treating neuropathic pain
WO2007121471A3 (en) Dialkyl ether delivery agents
WO2007143587A8 (en) Drug administration methods